GE HEALTHCARE TECHNOLOGY (GEHC) Fundamental Analysis & Valuation
NASDAQ:GEHC • US36266G1076
Current stock price
61.03 USD
+0.19 (+0.31%)
At close:
60.81 USD
-0.22 (-0.36%)
After Hours:
This GEHC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. GEHC Profitability Analysis
1.1 Basic Checks
- GEHC had positive earnings in the past year.
- GEHC had a positive operating cash flow in the past year.
- Each year in the past 5 years GEHC has been profitable.
- GEHC had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- Looking at the Return On Assets, with a value of 5.65%, GEHC belongs to the top of the industry, outperforming 81.91% of the companies in the same industry.
- GEHC has a Return On Equity of 20.09%. This is amongst the best in the industry. GEHC outperforms 94.15% of its industry peers.
- Looking at the Return On Invested Capital, with a value of 7.81%, GEHC belongs to the top of the industry, outperforming 82.45% of the companies in the same industry.
- Measured over the past 3 years, the Average Return On Invested Capital for GEHC is in line with the industry average of 9.14%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.65% | ||
| ROE | 20.09% | ||
| ROIC | 7.81% |
ROA(3y)5.31%
ROA(5y)6.29%
ROE(3y)21.03%
ROE(5y)19.41%
ROIC(3y)8.25%
ROIC(5y)9.14%
1.3 Margins
- GEHC has a Profit Margin of 10.11%. This is amongst the best in the industry. GEHC outperforms 83.51% of its industry peers.
- In the last couple of years the Profit Margin of GEHC has declined.
- GEHC has a Operating Margin of 13.40%. This is amongst the best in the industry. GEHC outperforms 81.91% of its industry peers.
- GEHC's Operating Margin has declined in the last couple of years.
- With a Gross Margin value of 39.98%, GEHC is not doing good in the industry: 67.02% of the companies in the same industry are doing better.
- In the last couple of years the Gross Margin of GEHC has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.4% | ||
| PM (TTM) | 10.11% | ||
| GM | 39.98% |
OM growth 3Y-0.87%
OM growth 5Y-3.3%
PM growth 3Y-1.1%
PM growth 5Y-34%
GM growth 3Y0.71%
GM growth 5Y0.28%
2. GEHC Health Analysis
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so GEHC is still creating some value.
- Compared to 1 year ago, GEHC has less shares outstanding
- The number of shares outstanding for GEHC has been increased compared to 5 years ago.
- The debt/assets ratio for GEHC has remained at the same level compared to a year ago.
2.2 Solvency
- Based on the Altman-Z score of 1.75, we must say that GEHC is in the distress zone and has some risk of bankruptcy.
- GEHC's Altman-Z score of 1.75 is in line compared to the rest of the industry. GEHC outperforms 56.38% of its industry peers.
- The Debt to FCF ratio of GEHC is 6.67, which is on the high side as it means it would take GEHC, 6.67 years of fcf income to pay off all of its debts.
- With a decent Debt to FCF ratio value of 6.67, GEHC is doing good in the industry, outperforming 73.94% of the companies in the same industry.
- A Debt/Equity ratio of 0.92 indicates that GEHC is somewhat dependend on debt financing.
- Looking at the Debt to Equity ratio, with a value of 0.92, GEHC is doing worse than 75.53% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.92 | ||
| Debt/FCF | 6.67 | ||
| Altman-Z | 1.75 |
ROIC/WACC1
WACC7.83%
2.3 Liquidity
- GEHC has a Current Ratio of 1.37. This is a normal value and indicates that GEHC is financially healthy and should not expect problems in meeting its short term obligations.
- GEHC's Current ratio of 1.37 is on the low side compared to the rest of the industry. GEHC is outperformed by 81.38% of its industry peers.
- A Quick Ratio of 1.13 indicates that GEHC should not have too much problems paying its short term obligations.
- Looking at the Quick ratio, with a value of 1.13, GEHC is doing worse than 76.60% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.37 | ||
| Quick Ratio | 1.13 |
3. GEHC Growth Analysis
3.1 Past
- The earnings per share for GEHC have decreased by -0.87% in the last year.
- The earnings per share for GEHC have been decreasing by -31.63% on average. This is quite bad
- The Revenue has been growing slightly by 4.84% in the past year.
- Measured over the past years, GEHC shows a small growth in Revenue. The Revenue has been growing by 3.74% on average per year.
EPS 1Y (TTM)-0.87%
EPS 3Y2.54%
EPS 5Y-31.63%
EPS Q2Q%-1.98%
Revenue 1Y (TTM)4.84%
Revenue growth 3Y3.99%
Revenue growth 5Y3.74%
Sales Q2Q%7.41%
3.2 Future
- GEHC is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.20% yearly.
- The Revenue is expected to grow by 4.24% on average over the next years.
EPS Next Y9.28%
EPS Next 2Y9.57%
EPS Next 3Y9.94%
EPS Next 5Y8.2%
Revenue Next Year6.03%
Revenue Next 2Y5.29%
Revenue Next 3Y5.05%
Revenue Next 5Y4.24%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. GEHC Valuation Analysis
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 13.38, GEHC is valued correctly.
- GEHC's Price/Earnings ratio is rather cheap when compared to the industry. GEHC is cheaper than 88.30% of the companies in the same industry.
- When comparing the Price/Earnings ratio of GEHC to the average of the S&P500 Index (26.51), we can say GEHC is valued slightly cheaper.
- A Price/Forward Earnings ratio of 11.10 indicates a reasonable valuation of GEHC.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of GEHC indicates a rather cheap valuation: GEHC is cheaper than 92.55% of the companies listed in the same industry.
- GEHC is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 21.41, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.38 | ||
| Fwd PE | 11.1 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, GEHC is valued cheaply inside the industry as 90.96% of the companies are valued more expensively.
- Based on the Price/Free Cash Flow ratio, GEHC is valued cheaply inside the industry as 89.89% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 18.5 | ||
| EV/EBITDA | 10 |
4.3 Compensation for Growth
- The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- The decent profitability rating of GEHC may justify a higher PE ratio.
PEG (NY)1.44
PEG (5Y)N/A
EPS Next 2Y9.57%
EPS Next 3Y9.94%
5. GEHC Dividend Analysis
5.1 Amount
- GEHC has a yearly dividend return of 0.23%, which is pretty low.
- In the last 3 months the price of GEHC has falen by -22.72%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
- GEHC's Dividend Yield is rather good when compared to the industry average which is at 0.26. GEHC pays more dividend than 89.36% of the companies in the same industry.
- With a Dividend Yield of 0.23, GEHC pays less dividend than the S&P500 average, which is at 1.80.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.23% |
5.2 History
- GEHC has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years2
Div Non Decr Years2
5.3 Sustainability
- 3.07% of the earnings are spent on dividend by GEHC. This is a low number and sustainable payout ratio.
DP3.07%
EPS Next 2Y9.57%
EPS Next 3Y9.94%
GEHC Fundamentals: All Metrics, Ratios and Statistics
61.03
+0.19 (+0.31%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Industry Strength11.18
Industry Growth59.01
Earnings (Last)04-29 2026-04-29/bmo
Earnings (Next)07-27 2026-07-27
Inst Owners93.2%
Inst Owner Change-7.65%
Ins Owners0.35%
Ins Owner Change0.66%
Market Cap27.85B
Revenue(TTM)20.63B
Net Income(TTM)2.08B
Analysts77.86
Price Target93 (52.38%)
Short Float %2.67%
Short Ratio3.48
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.23% |
Yearly Dividend0.14
Dividend Growth(5Y)N/A
DP3.07%
Div Incr Years2
Div Non Decr Years2
Ex-Date04-02 2026-04-02 (0.035)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.4%
Min EPS beat(2)-0.16%
Max EPS beat(2)0.96%
EPS beat(4)3
Avg EPS beat(4)5.61%
Min EPS beat(4)-0.16%
Max EPS beat(4)13.24%
EPS beat(8)6
Avg EPS beat(8)4.83%
EPS beat(12)10
Avg EPS beat(12)5.31%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-0.59%
Min Revenue beat(2)-0.75%
Max Revenue beat(2)-0.44%
Revenue beat(4)1
Avg Revenue beat(4)-0.46%
Min Revenue beat(4)-1.09%
Max Revenue beat(4)0.42%
Revenue beat(8)1
Avg Revenue beat(8)-1.72%
Revenue beat(12)2
Avg Revenue beat(12)-1.42%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.08%
PT rev (3m)-0.59%
EPS NQ rev (1m)0.25%
EPS NQ rev (3m)5.2%
EPS NY rev (1m)-0.02%
EPS NY rev (3m)2.65%
Revenue NQ rev (1m)0.04%
Revenue NQ rev (3m)0.65%
Revenue NY rev (1m)0.05%
Revenue NY rev (3m)1.15%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.38 | ||
| Fwd PE | 11.1 | ||
| P/S | 1.35 | ||
| P/FCF | 18.5 | ||
| P/OCF | 14.01 | ||
| P/B | 2.68 | ||
| P/tB | N/A | ||
| EV/EBITDA | 10 |
EPS(TTM)4.56
EY7.47%
EPS(NY)5.5
Fwd EY9.01%
FCF(TTM)3.3
FCFY5.4%
OCF(TTM)4.35
OCFY7.14%
SpS45.2
BVpS22.75
TBVpS-9.29
PEG (NY)1.44
PEG (5Y)N/A
Graham Number48.3093 (-20.84%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.65% | ||
| ROE | 20.09% | ||
| ROCE | 9.94% | ||
| ROIC | 7.81% | ||
| ROICexc | 9.32% | ||
| ROICexgc | 25% | ||
| OM | 13.4% | ||
| PM (TTM) | 10.11% | ||
| GM | 39.98% | ||
| FCFM | 7.3% |
ROA(3y)5.31%
ROA(5y)6.29%
ROE(3y)21.03%
ROE(5y)19.41%
ROIC(3y)8.25%
ROIC(5y)9.14%
ROICexc(3y)9.48%
ROICexc(5y)10.1%
ROICexgc(3y)28.41%
ROICexgc(5y)36.05%
ROCE(3y)10.49%
ROCE(5y)11.63%
ROICexgc growth 3Y-16.74%
ROICexgc growth 5Y-17.72%
ROICexc growth 3Y-3.85%
ROICexc growth 5Y-6.16%
OM growth 3Y-0.87%
OM growth 5Y-3.3%
PM growth 3Y-1.1%
PM growth 5Y-34%
GM growth 3Y0.71%
GM growth 5Y0.28%
F-Score4
Asset Turnover0.56
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.92 | ||
| Debt/FCF | 6.67 | ||
| Debt/EBITDA | 2.85 | ||
| Cap/Depr | 83.39% | ||
| Cap/Sales | 2.34% | ||
| Interest Coverage | 5.29 | ||
| Cash Conversion | 59.47% | ||
| Profit Quality | 72.18% | ||
| Current Ratio | 1.37 | ||
| Quick Ratio | 1.13 | ||
| Altman-Z | 1.75 |
F-Score4
WACC7.83%
ROIC/WACC1
Cap/Depr(3y)71.99%
Cap/Depr(5y)60.92%
Cap/Sales(3y)2.12%
Cap/Sales(5y)1.89%
Profit Quality(3y)91.25%
Profit Quality(5y)85.67%
High Growth Momentum
Growth
EPS 1Y (TTM)-0.87%
EPS 3Y2.54%
EPS 5Y-31.63%
EPS Q2Q%-1.98%
EPS Next Y9.28%
EPS Next 2Y9.57%
EPS Next 3Y9.94%
EPS Next 5Y8.2%
Revenue 1Y (TTM)4.84%
Revenue growth 3Y3.99%
Revenue growth 5Y3.74%
Sales Q2Q%7.41%
Revenue Next Year6.03%
Revenue Next 2Y5.29%
Revenue Next 3Y5.05%
Revenue Next 5Y4.24%
EBIT growth 1Y5.26%
EBIT growth 3Y3.09%
EBIT growth 5Y0.31%
EBIT Next Year28.45%
EBIT Next 3Y13.91%
EBIT Next 5Y12.12%
FCF growth 1Y-2.9%
FCF growth 3Y-5.84%
FCF growth 5Y-8.6%
OCF growth 1Y1.85%
OCF growth 3Y-2.03%
OCF growth 5Y-5.37%
GE HEALTHCARE TECHNOLOGY / GEHC Fundamental Analysis FAQ
What is the fundamental rating for GEHC stock?
ChartMill assigns a fundamental rating of 5 / 10 to GEHC.
What is the valuation status for GEHC stock?
ChartMill assigns a valuation rating of 7 / 10 to GE HEALTHCARE TECHNOLOGY (GEHC). This can be considered as Undervalued.
Can you provide the profitability details for GE HEALTHCARE TECHNOLOGY?
GE HEALTHCARE TECHNOLOGY (GEHC) has a profitability rating of 7 / 10.
What are the PE and PB ratios of GE HEALTHCARE TECHNOLOGY (GEHC) stock?
The Price/Earnings (PE) ratio for GE HEALTHCARE TECHNOLOGY (GEHC) is 13.38 and the Price/Book (PB) ratio is 2.68.
What is the earnings growth outlook for GE HEALTHCARE TECHNOLOGY?
The Earnings per Share (EPS) of GE HEALTHCARE TECHNOLOGY (GEHC) is expected to grow by 9.28% in the next year.